TELO Telomir Pharmaceuticals Corp: Market Value

Official company branding of Telomir Pharmaceuticals Corp (TELO)

The price trend shown below for Telomir Pharmaceuticals (TELO), which has a market capitalization of 0.04, reflects the dynamics of a biotech project focused on creating anti-aging molecules. Telomir Pharmaceuticals is developing a closed-loop research cycle for telomere protection, establishing significant barriers to entry for competitors. However, investors face the risk of a total loss of capital due to a questionable scientific foundation and regulatory threats. A lack of commercial reach and rising laboratory costs only further delay the achievement of operational efficiency.

TELO Telomir Pharmaceuticals, Inc.: Market Value in the range 02/21/2024 - 11/16/2026

Comprehensive metric breakdowns and analytics for Telomir Pharmaceuticals (TELO)

- current price and projected stock value:
Fundamental company analysis:TELO (Telomir Pharma)
Product sample of Telomir Pharmaceuticals Corp

The market capitalization of Telomir Pharmaceuticals (TELO) reflects the aggregate value of the business within the anti-aging sector. This metric is calculated as the product of the current share price and the total volume of outstanding shares. By analyzing the company's market cap history, an investor sees the real-time market reaction to liquidity. This valuation trend captures the value of a compact staff of unique biologists. Stable capital ensures the autonomy of the scientists and the efficiency of their research.

Key competitors

Market Value Haleon Group HLN|Kenvue Inc. - Market Value|VRNA - Market Value|MENS (jyongbio.com) - Market Capitalization|LGND: Market Capitalization|Market Capitalization AMRX|Market Value Perrigo|Alvotech Corp - Market Valuation|Market Capitalization LQDA|GLPG (Galapagos NV) - Market Value|Market Capitalization ANIP (anipharmaceuticals.com)|Market Capitalization MannKind Corp MNKD|AMPH - Market Value|Market Value PCRX (Pacira Corp)|ars-pharma.com (SPRY) - Market Value|Market Valuation Theravance Biopharma|AQST (aquestive.com) - Market Capitalization|Market Capitalization scPharmaceuticals|Market Valuation TECX (Tectonic Therapeutic Inc.)|TNXP (Tonix Pharmaceuticals Holding) - Market Value|Market Value China SXT Pharmaceuticals, Inc. SXTC|eupraxiapharma.com (EPRX) - Market Value|BHST: Market Valuation|eXoZymes - Market Value|ORMP: Market Capitalization|Entera Bio Ltd - Market Value|HYFT (MindWalk Holdings, Inc.) - Market Capitalization|Market Value abvcpharma.com ABVC|Market Value Cumberland Pharmaceuticals Inc. (CPIX)|QNTM (Quantum BioPharma Ltd.) - Market Value|Market Capitalization FGEN (FibroGen)|Market Value RANI|SNYR: Market Valuation|RLYB - Market Capitalization|LEXX (Lexaria Bioscience) - Market Valuation|PULM (Pulmatrix Inc) - Market Value|Market Valuation PTHL|APM: Market Value|Market Valuation LYRA (Lyra Therapeutics, Inc.)|Market Value IBO|Market Capitalization TNFA (TNF Pharmaceuticals)|Market Value YCBD|PainReform - Market Capitalization|Market Value CYTO (altamiratherapeutics.com)|LIPO (Lipella Pharmaceuticals) - Market Valuation|Market Value OptiNose (OPTN)|PIRS (Pieris Pharmaceuticals, Inc.) - Market Capitalization|PROC - Market Capitalization|Market Capitalization PTPI|QLI - Market Value|Market Value ACELYRIN SLRN|TFFP - Market Valuation